Accessibility Menu
Encompass Health logo

Encompass Health(NYSE) EHC

Market Cap$11.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1986)+3,381%
5 Year+104%
1 Year-3%
1 Month+3%
Premium Feature
Moneyball Superscore
73/100
$120.97
+1.17%
+1.40Today
After hours$120.83-$0.14 (-0.12%)
Encompass Health last closing stock price
MetricPriceDate
Last closeUSD 119.572026-08-27
Encompass Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.11%USD 120.912026-08-20
1 month+3.05%USD 116.032026-07-28
3 month+13.17%USD 105.652026-05-29
Year to date+13.29%USD 105.542025-12-31
1 year-2.55%USD 122.702025-08-27
3 year+74.63%USD 68.472023-08-28
5 year+103.98%USD 58.622021-08-27
Since inception+3,381.48%USD 3.431986-09-24

Encompass Health Financials at a Glance

Market Cap

$11.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.21B

Net Income (TTM)

$621.00M

EPS (TTM)

$6.14

P/E Ratio

19.47

Dividend

$0.76

Beta (Volatility)

0.57 (Low)

Price

$120.97

Volume

887,881.009

Open

$120.43

Previous Close

$120.85

Daily Range

$118.99 - $121.66

52-Week Range

$92.77 - $127.99

Estimated Earnings Date

Oct 28, 2026

EHC: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Encompass Health

Encompass Health Corporation helps people recover after serious medical events. Patients receive intensive therapy in specialized hospitals for conditions like strokes or brain injuries. The company makes it easier for individuals to return to their daily lives.

Where Specialized Therapy Happens

  • Inpatient Rehabilitation: Specialized hospitals providing intensive recovery treatment for adults after major medical events; accounted for $1.6 billion in net operating revenues during the quarter ended June 30, 2026.
  • Neurological and Orthopedic Care: Comprehensive treatment programs for individuals recovering from brain injuries, spinal cord injuries, and complex bone conditions.
  • Medicare Services: Healthcare programs for patients using federal insurance; represented 65.8% of net operating revenues in the three-month period ended June 30, 2026.
  • Medicare Advantage Plans: Care provided through private health insurance alternatives to traditional Medicare; accounted for 16.2% of net operating revenues in the second quarter of 2026.
  • Managed Care Programs: Coordinated health services provided via private insurance companies; made up 10.7% of net operating revenues for the three-month period ended June 30, 2026.

Expanding the Hospital Network

  • Opened new hospitals in South Carolina, Pennsylvania, and Georgia during the first six months of 2026.
  • Added 54 beds to existing hospital locations to increase patient capacity in early 2026.
  • Announced development plans for 11 future hospitals in states including Florida, Texas, and Utah.
  • Issued $500 million in senior notes in May 2026 to manage existing debt and fund growth initiatives.

Why the Network Stands Out

Encompass Health is the largest operator of inpatient rehabilitation hospitals in the United States based on revenue and patient count. Its operational strength comes from specialized clinical technology and a flexible capital structure with no significant debt maturities until 2028.

Recent Financial Performance

  • Net operating revenues reached $1.6 billion in the three-month period ended June 30, 2026, up 9.6% year over year.
  • Total inpatient discharges were 68,895 in the quarter ended June 30, 2026, up 5.6% year over year.
  • Net income attributable to the company was $153.9 million in the second quarter of 2026, up 8.3% year over year.
  • The price-to-earnings ratio was 16.3 for the quarter ended June 30, 2026, compared to 21.7 in the same period of 2025.
  • Net cash provided by operating activities reached $595.7 million for the six-month period ended June 30, 2026.

Bottom Line

Encompass Health has solidified its position as a leader in post-acute care by expanding its physical hospital footprint. Its focus on specialized rehabilitation services aligns with the medical needs of an aging U.S. population.

AI Generated • Aug 8, 2026

Industry

Healthcare Providers and Services

Employees

42,300

CEO

Mark J. Tarr, MBA

Headquarters

Birmingham, AL 35242, US

EHC Financials

Key Financial Metrics (TTM)

Gross Margin

73.13%

Operating Margin

18.00%

Net Income Margin

10.01%

Return on Equity

25.01%

Return on Capital

20.44%

Return on Assets

8.33%

Earnings Yield

5.14%

Dividend Yield

0.64%

Payout Ratio

12.11%

Stock Overview

Market Cap

$11.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

98.65M

Volume

887.88K

Avg. Volume

1.00M

Financials (TTM)

Gross Profit

$4.54B

Operating Income

$1.12B

EBITDA

$1.50B

Operating Cash Flow

$1.21B

Capital Expenditure

-$799.10M

Free Cash Flow

$413.40M

Cash & ST Invst.

$107.70M

Total Debt

$2.84B

Encompass Health Performance Analysis

Encompass Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 4,348,600,0008.3%
20232023-12-31USD 4,801,200,00010.4%
20242024-12-31USD 5,373,200,00011.9%
20252025-12-31USD 5,935,200,00010.5%
Encompass Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.4%
Q42025-12-314.5%
Q12026-03-312.7%
Q22026-06-300.7%
Encompass Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 2.70-34.4%
20232023-12-31USD 3.4728.7%
20242024-12-31USD 4.4628.3%
20252025-12-31USD 5.5424.2%
Encompass Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-10.8%
Q42025-12-3115.3%
Q12026-03-3135.0%
Q22026-06-30-20.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.60B

+9.6%

Gross Profit

$1.60B

+154.8%

Gross Margin

100.00%

N/A

Market Cap

$11.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$397.18K

N/A

Employees

29,699

N/A

Net Income

$153.90M

+8.3%

EBITDA

$384.80M

+10.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$107.70M

-36.9%

Total Debt

$2.84B

+5.8%

Accounts Receivable

$687.30M

+12.2%

Inventory

$0.00

N/A

Long Term Debt

$2.78B

+10.2%

Short Term Debt

$63.40M

-61.5%

Return on Assets

8.33%

N/A

Return on Invested Capital

16.97%

N/A

Free Cash Flow

$62.30M

-45.0%

Operating Cash Flow

$282.60M

+4.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DVADaVita Inc.
$180.68+1.01%
ELANElanco Animal Health Incorporated
$24.11-1.55%
ALGNAlign Technology, Inc.
$157.58-0.79%
FMSFresenius Medical Care AG & Co. KGaA
$23.10-0.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About EHC

What is the current price of Encompass Health?

Encompass Health is trading at $120.85 per share.

What is the 52-week range for Encompass Health?

Over the past 52 weeks, Encompass Health has traded between $92.77 and $127.99.

How much debt does Encompass Health have?

As of the most recent reporting period, Encompass Health reported total debt of $2.84B.

How much cash does Encompass Health have on hand?

Encompass Health reported $133.50M in cash and cash equivalents in its most recent financial results.

What is Encompass Health’s dividend yield?

Encompass Health currently has a dividend yield of 0.64%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.